Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Gains from Sales and Divestitures (2016 - 2020)

Historic Gains from Sales and Divestitures for National Research (NRC) over the last 6 years, with Q4 2020 value amounting to $71378.0.

  • National Research's Gains from Sales and Divestitures changed N/A to $71378.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $71378.0, marking a year-over-year change of. This contributed to the annual value of $71378.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, National Research's Gains from Sales and Divestitures is $71378.0.
  • In the past 5 years, National Research's Gains from Sales and Divestitures ranged from a high of $73506.0 in Q4 2017 and a low of $13611.0 during Q2 2018
  • In the last 4 years, National Research's Gains from Sales and Divestitures had a median value of $20892.0 in 2016 and averaged $31095.9.
  • In the last 5 years, National Research's Gains from Sales and Divestitures surged by 25183.8% in 2017 and then plummeted by 8148.31% in 2018.
  • National Research's Gains from Sales and Divestitures (Quarter) stood at $20892.0 in 2016, then skyrocketed by 251.84% to $73506.0 in 2017, then crashed by 81.48% to $13611.0 in 2018, then soared by 424.41% to $71378.0 in 2020.
  • Its Gains from Sales and Divestitures stands at $71378.0 for Q4 2020, versus $34622.0 for Q3 2020 and $34622.0 for Q2 2020.